MedTrace Logo

Crux Biomedical Vena Cava Filter Study - United States

NCT01120509 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2014-06-30

No results posted yet for this study

Summary

The purpose of this study is to determine if the Crux Vena Cava Filter System is safe and effective in preventing pulmonary embolism.

Conditions

Interventions

DEVICE

Inferior Vena Cava Filter

Inplant of filter in inferior vena cava.

Sponsors & Collaborators

  • Crux Biomedical

    lead INDUSTRY

Principal Investigators

  • Robert Mendes, MD · University Hospital, Augusta, Georgia, USA

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-06-30
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01120509 on ClinicalTrials.gov